Biomimetic nanocarrier for direct cytosolic drug delivery.
about
Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsulesTargeting SR-BI for Cancer Diagnostics, Imaging and TherapyHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesHDL as a drug and nucleic acid delivery vehiclePharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticlesUnique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranosticsStudy of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors.Combined system of fluorescence diffuse optical tomography and microcomputed tomography for small animal imaging.SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer.Endocytosis of a functionally enhanced GFP-tagged transferrin receptor in CHO cells.Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging.Synthetic high-density lipoprotein-like nanoparticles for cancer therapyCore-shell nanocarriers with high paclitaxel loading for passive and active targeting.Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.Receptor-targeted nanocarriers for therapeutic delivery to cancer.Lipoprotein-inspired nanoparticles for cancer theranosticsStrategies in biomimetic surface engineering of nanoparticles for biomedical applications.Lipid-based nanoparticles in the systemic delivery of siRNA.Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective.Learning from biology: synthetic lipoproteins for drug delivery.Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan.Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles.QUANTIFYING NANOPARTICLE TRANSPORT IN VIVO USING HYPERSPECTRAL IMAGING WITH A DORSAL SKINFOLD WINDOW CHAMBER.Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles.Deep Tumor Penetrating Bioparticulates Inspired Burst Intracelluar Drug Release for Precision Chemo-Phototherapy.Using Fluorescence Imaging to Track Drug Delivery and Guide Treatment Planning In Vivo.Bottom up design of nanoparticles for anti-cancer diapeutics: "put the drug in the cancer's food".Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery.Self-assembling dipeptide-based nontoxic vesicles as carriers for drugs and other biologically important molecules.Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug deliveryReconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer TherapyNanostructure-Dependent Ratiometric NIR Fluorescence Enabled by Ordered Dye AggregationEfficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticlesSynthesis and Development of Lipoprotein-Based Nanocarriers for Light-Activated Theranostics
P2860
Q27339704-7E9C943F-49C4-4093-8F8A-B2D8810EEBC5Q28066708-75E4ACD9-0663-481B-9708-3CF0007BA49DQ28077290-FF649364-ABB0-4BD0-B55D-E65B57E956D4Q28083209-04812AE1-2E2A-4E38-8672-62B8358CD16AQ28084443-9CD9D0C2-84BB-40AE-B19B-3BD2751A3CB6Q30462417-42B685BD-0391-4170-929C-DBA2F1813516Q30470222-A50BB018-2DB8-411D-B6FF-C02086D3EE64Q33591601-78070466-7C93-4396-9341-CA282FBF7000Q33821120-14C54DCC-5D38-4F59-A290-D820013E7D54Q35214291-FBB439C4-098A-4335-BE98-9319B554913FQ35979595-BE010969-E988-4B42-9164-9C4B4D97F764Q36264073-66850740-ADED-46C3-BB8F-149A3044EC4EQ36986079-A34FB509-E67C-45C1-AB5E-DFB29411F390Q36997612-87A9F8EE-4905-40A5-8937-93E57316DF15Q37739791-AE31ECB8-7F5B-4518-91CF-E0BCABD33B82Q37804383-4E9FA107-FE1F-4FDA-9EEF-91EB2A46BE1AQ37873918-A8740F30-306B-4BE8-B632-16325F7025F3Q37963778-B130BC1B-D7CD-41D6-A8B5-B2B7E03C2337Q38172634-56E28FB1-42D0-4E9B-A2CF-06EFA5B1B088Q38180108-59327EEA-EA7A-4C54-AAE9-C6DD7AF22983Q38262882-A2B6DD79-5562-4B5F-83B4-0BF466AF5D9FQ38401839-B62464B7-E146-4665-8552-140A6CF460B9Q38403588-251AF719-7602-4CC0-8B09-9CEA6E663F3FQ38822339-7B8A1ED9-4193-4C9F-9D5D-4DE11556DACDQ39582387-A2362426-60D5-47A8-B27E-F64A23030ACEQ41533252-AF77E6DF-A57E-464D-8E8C-03466191EC22Q43559547-4A5F1AB0-44F4-4B0B-B269-7D871F10502FQ48269486-DB640343-FE8A-4C20-AF9B-3ABF82FC8E6CQ48611367-684D1E72-486E-4DD3-A89D-B8F2E75D6196Q51159201-F1F130A4-40A6-4366-A24D-35C961CDCABAQ55350285-9DA619EE-64F9-4FEB-8821-E27EF591855FQ55462917-569879EB-6FCA-4BDC-BE4A-C10F0C5AB676Q57377122-BC853C6C-4F53-4DA3-8710-026D03F0F09DQ58122191-68AD4D7A-BD15-4A2A-B02D-19F645885602Q59158930-0D8A16A6-69CF-4111-B1BB-A37C98661CD8Q59159078-6FED9ACC-ABC1-4BA3-8C61-0499126C5048Q59159093-A643501E-3D88-4D45-BA67-3C5E92928276
P2860
Biomimetic nanocarrier for direct cytosolic drug delivery.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Biomimetic nanocarrier for direct cytosolic drug delivery.
@en
Biomimetic nanocarrier for direct cytosolic drug delivery.
@nl
type
label
Biomimetic nanocarrier for direct cytosolic drug delivery.
@en
Biomimetic nanocarrier for direct cytosolic drug delivery.
@nl
prefLabel
Biomimetic nanocarrier for direct cytosolic drug delivery.
@en
Biomimetic nanocarrier for direct cytosolic drug delivery.
@nl
P2093
P50
P921
P356
P1476
Biomimetic nanocarrier for direct cytosolic drug delivery
@en
P2093
Ian Corbin
Qingming Luo
Weiguo Cao
Zhihong Zhang
P304
P356
10.1002/ANIE.200903112
P407
P577
2009-01-01T00:00:00Z